Literature DB >> 33875815

Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.

Yoshitaka Inoue1,2, Keiji Okinaka3, Shigeo Fuji4, Yoshihiro Inamoto3, Naoyuki Uchida5, Takashi Toya6, Kazuhiro Ikegame7, Tetsuya Eto8, Yukiyasu Ozawa9, Koji Iwato10, Yoshinobu Kanda11, Yoshiko Atsuta12,13, Masao Ogata14, Takahiro Fukuda3.   

Abstract

This study aimed to clarify the risk factors and prognosis associated with blood stream infection (BSI) in allogeneic hematopoietic cell transplantation (allo-HCT), and the relationship between BSI and acute graft-versus-host disease (aGVHD). This retrospective analysis included 11,098 patients in the Japanese national transplant registry. A total of 2172 patients developed BSI after allo-HCT, with 2332 identified pathogens. The cumulative incidences of BSI were 15.5% at 30 days and 20.9% at 100 days after allo-HCT. In a multivariate analysis, severe (grade III-IV) aGVHD was associated with a higher risk of BSI (vs. grade 0-I aGVHD: hazard ratio [HR] 3.34 [95% confidence interval (CI), 2.85-3.92; P < 0.001]). In a multivariate analysis, severe aGVHD before BSI was associated with a higher risk of overall mortality after BSI (vs. grade 0-I aGVHD: HR 2.61 [95% CI 2.18-3.11; P < 0.001]). In addition, BSI (vs. no-BSI: HR 1.20 [95% CI, 1.12-1.29; P < 0.001]) and severe aGVHD (vs. grade 0-I aGVHD: HR 1.97 [95% CI, 1.83-2.12; P < 0.001]) were independent risk factors for overall mortality after allo-HCT. In the setting of allo-HCT, severe aGVHD was associated with increases in both BSI incidence and post-BSI overall mortality. Furthermore, BSI was an independent risk factor for overall mortality.

Entities:  

Year:  2021        PMID: 33875815     DOI: 10.1038/s41409-021-01291-0

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  39 in total

1.  Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.

Authors:  Jo-Anne H Young; Brent R Logan; Juan Wu; John R Wingard; Daniel J Weisdorf; Cathryn Mudrick; Kristin Knust; Mary M Horowitz; Dennis L Confer; Erik R Dubberke; Steven A Pergam; Francisco M Marty; Lynne M Strasfeld; Janice Wes M Brown; Amelia A Langston; Mindy G Schuster; Daniel R Kaul; Stanley I Martin; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-25       Impact factor: 5.742

2.  Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.

Authors:  M Mikulska; V Del Bono; P Bruzzi; A M Raiola; F Gualandi; M T Van Lint; A Bacigalupo; C Viscoli
Journal:  Infection       Date:  2011-12-21       Impact factor: 3.553

3.  Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).

Authors:  M Weisser; C Theilacker; S Tschudin Sutter; R Babikir; H Bertz; T Götting; M Dettenkofer; W V Kern; A F Widmer
Journal:  Clin Microbiol Infect       Date:  2017-03-31       Impact factor: 8.067

4.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.

Authors:  B A Collin; H L Leather; J R Wingard; R Ramphal
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.

Authors:  A Busca; I Cavecchia; F Locatelli; S D'Ardia; F G De Rosa; F Marmont; G Ciccone; I Baldi; R Serra; E Gaido; M Falda
Journal:  Transpl Infect Dis       Date:  2011-05-22       Impact factor: 2.228

6.  Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000.

Authors:  Mar Ortega; Montserrat Rovira; Manel Almela; Francesc Marco; Jorge Puig de la Bellacasa; José Antonio Martínez; Enric Carreras; Josep Mensa
Journal:  Ann Hematol       Date:  2004-10-12       Impact factor: 3.673

7.  Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

Authors:  Malgorzata Mikulska; Valerio Del Bono; Anna Maria Raiola; Barbara Bruno; Francesca Gualandi; Domenico Occhini; Carmen di Grazia; Francesco Frassoni; Andrea Bacigalupo; Claudio Viscoli
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

8.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.

Authors:  D D Poutsiaka; L L Price; A Ucuzian; G W Chan; K B Miller; D R Snydman
Journal:  Bone Marrow Transplant       Date:  2007-04-30       Impact factor: 5.483

9.  Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.

Authors:  C Gudiol; C Garcia-Vidal; M Arnan; I Sánchez-Ortega; B Patiño; R Duarte; J Carratalà
Journal:  Bone Marrow Transplant       Date:  2014-03-24       Impact factor: 5.483

10.  Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.

Authors:  O Blennow; P Ljungman; E Sparrelid; J Mattsson; M Remberger
Journal:  Transpl Infect Dis       Date:  2013-12-30       Impact factor: 2.228

View more
  1 in total

1.  The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.

Authors:  Sook-Kyoung Heo; Eui-Kyu Noh; Yoo Jin Lee; Yerang Shin; Youjin Kim; Hyeon-Su Im; Hyeyeong Kim; Su Jin Koh; Young Joo Min; Jae-Cheol Jo; Yunsuk Choi
Journal:  BMC Cancer       Date:  2022-09-20       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.